Ultrasonic Spray Nozzles Industry Expertise Products Company Investors Customer Reviews
  • Categories >>
  • Electronics
  • Energy
  • Medical
  • Glass
  • Food
  • Textiles
  • Nanotechnology
  • Industrial
  • Categories >>
  • Electronics
  • Energy
  • Medical
  • Glass
  • Food
  • Textiles
  • Nanotechnology
  • Industrial
test

FY2015 Q1 Estimate & Video Interview with CEO Chris Coccio

Sono-Tek (OTCQB: SOTK) announces that the preliminary first quarter sales estimate will be approximately $50K above last year’s first quarter figure of $2353K, in spite of slower business climate in the US for that period. The final sales figure and associated income will be available after auditing by July 15, 2015. In addition, our backlog for Q2 is increasing and we expect a further sales increase in that quarter.

In addition, CEO Chris Coccio was interviewed at the Marcum Microcap Conference held recently in New York City, and that four minute video can be seen at the following web address: http://www.equities.com/media-gallery/277-dr-christopher-l-coccio-chairman-and-ceo-of-sono-tek-corp The video is aired on equities.com and outlines Sono-Tek’s company overview, growth prospects, and FY2014 highlights.

Dr.-Coccio-video-interview

In the interview, Dr. Coccio also outlines SOTK’s competitive edge and what sets the Company apart from our competitors, and provides some insight into the Company’s history and key growth potential applications.

Click the link above to see this comprehensive video for a succinct snapshot of current SOTK investor information or go to the investor section of our website http://www.sono-tek.com/investor-relations/ for more information.

This news release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, competitive and technological developments affecting our operations or the demand for our products; timely development and market acceptance of new products; adequacy of financing; capacity additions, the ability to enforce patents, acceptance of our advanced medical device platform; continued penetration into the food coating and solar energy markets and the ability to achieve increased sales volume at projected levels and continued profitability. We refer you to documents that the company files with the Securities and Exchange Commission, which includes Form 10-K and Form 10-Qs containing additional important information.